Patents by Inventor Dana Vanderwall

Dana Vanderwall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CCR5 antagonists as therapeutic agents
    Patent number: 7645771
    Abstract: The present invention relates to compounds of formula (I) or a pharmaceutically acceptable derivatives thereof, useful in the treatment of prophylazis of CCR5-related diseases and disorders, for example, in the inhibition of HIV replication, the prevention or treatment of HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
    Type: Grant
    Filed: December 12, 2003
    Date of Patent: January 12, 2010
    Assignee: SmithKline Beecham Corp.
    Inventors: Wieslaw Mieczyslaw Kazmierski, Chrisopher Joseph Aquino, Neil Bifulco, Eric Eugene Boros, Brian Andrew Chauder, Pek Yoke Chong, Maosheng Duan, Felix Deanda, Jr., Cecilia Suarez Koble, Ed Williams McLean, Jennifer Poole Peckham, Angilique C Perkins, James Benjamin Thompson, Dana Vanderwall
  • Ccr5 antagonists as therapeutic agents
    Publication number: 20060229336
    Abstract: The present invention relates to compounds of formula (I) or a pharmaceutically acceptable derivatives thereof, useful in the treatment of prophylazis of CCR5-related diseases and disorders, for example, in the inhibition of HIV replication, the prevention or treatment of HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
    Type: Application
    Filed: December 12, 2003
    Publication date: October 12, 2006
    Inventors: Wieslaw Kazmierski, Chrisopher Aquino, Neil Bifulco, Eric Boros, Brian Chauder, Pek Chong, Maosheng Duan, Felix Deanda, Cecilia Koble, Ed Mclean, Jennifer Peckham, Angilique Perkins, James Thompson, Dana Vanderwall
  • Thienopyrimidine compounds as protein tyrosine kinase inhibitors
    Publication number: 20050009845
    Abstract: The present invention relates to thienopyrmidine compounds of formula (I) (one of A1 and A2 is S and the other is CH), salts thereof, as well as use and preparation of the same. These compounds are inhibitors of various protein tyrosine kinases (PTKs) of the ErbB family and consequently are useful in the treatment of disorders mediated by aberrant activity of such kinases.
    Type: Application
    Filed: December 13, 2002
    Publication date: January 13, 2005
    Inventors: Thomas Caferro, Stanley Chamberlain, Kelly Donaldson, Philip Harris, Michael Gaul, David Uehling, Dana Vanderwall